Also known as: cannabis for athletic recovery · CBD for sports performance · THC and exercise

Cannabis and Athletic Performance

An evidence-focused guide to cannabis use in athletic training and recovery.

Automated fact-check pass
14 cited sources
Published
Last reviewed
How this page was made

This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.

↯ The honest take

Cannabis marketing to athletes is aggressive and mostly ahead of the science. THC impairs athletic performance — period. CBD for sleep and pain is plausible but evidence in athletes is small-scale. For persistent pain from old injuries, talk to a doctor about all treatment options, including whether cannabis is appropriate. Otherwise, standard recovery methods (sleep, nutrition, training load) win.

Not medical advice

This article is not medical advice. It summarizes published evidence as of October 2026. Cannabis interacts with medications, affects coordination and judgment, and is regulated differently across jurisdictions and sport governing bodies. Talk to a clinician familiar with your sport, your health, and your local laws before using cannabis around training or competition. Drug testing rules — including WADA's THC threshold Strong evidence [1] — apply regardless of legality where you live.

Plain-language summary

Athletes use cannabis for three main reasons: to manage pain and inflammation, to sleep better, and to manage anxiety. Here's what the evidence actually shows:

The honest bottom line: CBD is low-risk and might modestly help sleep and recovery. THC is fine recreationally but treat it like alcohol around training — it has real costs.

What probably works

Very little reaches the 'probably works' threshold specifically in athletes.

CBD for sleep onset and subjective sleep quality. Small trials and case reports show modest improvements in self-reported sleep, particularly in people with anxiety or pain interfering with rest Weak / limited [6][7]. Sleep is the single most important recovery variable, so even modest effects matter. Note: long-term use data are limited, and chronic THC reduces REM sleep Strong evidence [8].

THC and/or CBD for chronic pain that interferes with training. The general chronic pain literature shows small-to-moderate benefit from cannabinoids Strong evidence [9].

What might work (weak or preliminary evidence)

CBD for exercise-induced inflammation and DOMS (delayed-onset muscle soreness). Preclinical and a handful of small human studies suggest CBD may reduce inflammatory markers and subjective soreness Weak / limited [3][10]. Effect sizes are small and study protocols vary widely; generalization to broader athlete populations is premature.

CBD for pre-competition anxiety. Controlled trials show CBD reduces anxiety in social anxiety models at doses of 300–600 mg Weak / limited [11]. Whether this translates to performance benefit — versus simply feeling calmer while losing the arousal sharpness needed for peak output — is unclear.

Cannabinoids for traumatic brain injury and concussion recovery. Mechanistic and animal data are interesting Weak / limited [12]. No adequately powered human trials in athletes exist. Anyone marketing CBD as a concussion treatment is ahead of the evidence.

Topical CBD for localized soreness. Biologically plausible, but transdermal CBD absorption is poor and human data are minimal Weak / limited.

What doesn't work or has weak evidence

THC as a performance enhancer. This is a persistent myth in some athletic subcultures. Multiple controlled studies show THC either impairs or produces no measurable benefit for endurance, strength, reaction time, and coordination Strong evidence [1][2]. WADA bans it in-competition because of both performance and safety concerns.

Cannabis 'replacing' NSAIDs wholesale. A popular framing in endurance and combat sports communities. The chronic-NSAID problem (GI bleeding, kidney dysfunction) is real, but direct evidence showing cannabinoids match NSAID efficacy for acute exercise inflammation does not exist Weak / limited.

Specific terpene performance claims (e.g., 'myrcene relaxes muscles,' 'pinene improves breathing for runners'). These extrapolate from in vitro lab work and aromatherapy folklore, not athlete trials No data.

'Indica for recovery, sativa for training.' The indica/sativa distinction does not reliably predict effects Disputed [13].

Marketing tricks ('mango boosts your high,' 'fatty meals enhance effects') are folklore without controlled research Anecdote.

What we don't know

Comparison with standard treatments

The evidence does not support cannabis as a performance or recovery tool; for persistent pain, treatment decisions belong with a doctor.

Risks

Drug testing and doping rules. WADA permits CBD but bans THC above 150 ng/mL urine Strong evidence [1]. CBD products are frequently contaminated with THC; athletes have failed drug tests this way Weak / limited [14].

Cardiovascular load during exercise. THC acutely raises heart rate and increases myocardial oxygen demand Strong evidence [1]. Combining heavy exertion with acute THC use is not advisable, particularly for older athletes or those with cardiac risk factors.

Impaired coordination and reaction time. Acute THC impairs both Strong evidence [1]. This is dangerous in contact sports, combat sports, and motor sports where precision is critical.

Sleep architecture disruption. Chronic THC reduces REM sleep; tolerance develops and rebound insomnia occurs on cessation Strong evidence [8].

Cannabis hyperemesis syndrome. With heavy chronic use, intractable nausea and vomiting occur — disastrous for an athlete's nutrition and hydration Strong evidence.

Smoking and respiratory health. Any smoking irritates airways. Vaporization or oral routes are preferable for endurance athletes Strong evidence.

Cannabis use disorder. Approximately 10% of users develop dependence; rates are higher in daily users Strong evidence.

Sources

  1. Peer-reviewed Kennedy MC. Cannabis: Exercise performance and sport. A systematic review. Journal of Science and Medicine in Sport, 2017;20(9):825-829.
  2. Peer-reviewed Ware MA, Jensen D, Barrette A, Vernec A, Derman W. Cannabis and the Health and Performance of the Elite Athlete. Clinical Journal of Sport Medicine, 2018;28(5):480-484.
  3. Peer-reviewed McCartney D, Benson MJ, Desbrow B, Irwin C, Suraev A, McGregor IS. Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research. Sports Medicine - Open, 2020;6:27.
  4. Peer-reviewed Rojas-Valverde D. Potential Role of Cannabidiol on Sports Recovery: A Narrative Review. Frontiers in Physiology, 2021;12:722550.
  5. Peer-reviewed Raichlen DA, Foster AD, Gerdeman GL, Seillier A, Giuffrida A. Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high'. Journal of Experimental Biology, 2012;215(8):1331-1336.
  6. Peer-reviewed Babson KA, Sottile J, Morabito D. Cannabis, Cannabinoids, and Sleep: a Review of the Literature. Current Psychiatry Reports, 2017;19(4):23.
  7. Peer-reviewed Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in Anxiety and Sleep: A Large Case Series. The Permanente Journal, 2019;23:18-041.
  8. Government National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press, 2017.
  9. Peer-reviewed Isenmann E, Veit S, Starke L, Flenker U, Diel P. Effects of Cannabidiol Supplementation on Skeletal Muscle Regeneration after Intensive Resistance Training. Nutrients, 2021;13(9):3028.
  10. Peer-reviewed Bergamaschi MM, Queiroz RH, Chagas MH, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology, 2011;36(6):1219-1226.
  11. Peer-reviewed Schurman LD, Lichtman AH. Endocannabinoids: A Promising Impact for Traumatic Brain Injury. Frontiers in Pharmacology, 2017;8:69.
  12. Peer-reviewed Piomelli D, Russo EB. The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 2016;1(1):44-46.
  13. Peer-reviewed Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA, 2017;318(17):1708-1709.
  14. Peer-reviewed Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. JAMA Psychiatry, 2015;72(12):1235-1242.

How this page was made

Generation history

Oct 30, 2026
Revision
Oct 30, 2026
Fact-check pass — raised 8 flags
May 11, 2026
Fact-check pass — raised 3 flags
May 11, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.